AI-generated summary
The authors studied 18 recreational male runners in a randomized, double-blind, placebo-controlled trial comparing photobiomodulation at three doses with placebo and control during submaximal running. They report that the 15 J per site dose showed likely beneficial effects on neuromuscular economy at 9 km/h, while the 30 and 60 J doses showed only possible beneficial effects at that speed.
- Participants
- 18
- Who or what was studied
- 18 male recreational runners
- Wavelengths
- 850, 670, 880, 950 nm
- Limits stated in the abstract
- The abstract reports a small sample of recreational runners and relies on magnitude-based inference, with some effects described only as possible or small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm, 670 nm, 880 nm, 950 nm
- Total energy
- 60 J, 15 J, 420 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Dose, Photobiomodulation, Placebo-controlled, Effect size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.